Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study
Publication year
2019Source
Prostate Cancer and Prostatic Diseases, 22, 1, (2019), pp. 101-109ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Operating Rooms
Urology
Journal title
Prostate Cancer and Prostatic Diseases
Volume
vol. 22
Issue
iss. 1
Page start
p. 101
Page end
p. 109
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 15: Urological cancers RIHS: Radboud Institute for Health Sciences; Radboudumc 15: Urological cancers RIMLS: Radboud Institute for Molecular Life SciencesThis item appears in the following Collection(s)
- Academic publications [204996]
- Faculty of Medical Sciences [81051]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.